Online psychoeducation to improve well-being after breast cancer
The Effect of a Web-Based Supportive Psychoeducation Program on Psychological Well-Being, Quality of Life and Fear of Recurrence Applied to Patients Who Completed Active Breast Cancer Treatment
This trial tests whether a 6-week online psychoeducation program can help women who finished breast cancer treatment at least a year ago feel better psychologically and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 72 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | Female |
| Sponsor | Uskudar University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT07284030 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial will enroll 72 female breast cancer survivors in remission for at least 12 months and randomly assign them to either a 6-week web-based psychoeducation program plus standard care or to standard care alone. The intervention is delivered weekly via live 30-45 minute Zoom sessions on coping strategies, psychosocial adjustment, meaning, and hope through the onkodestek.org platform. Outcomes including psychological well-being, fear of cancer recurrence, quality of life, and hopelessness are measured at baseline, immediately post-intervention, and at a 2-month follow-up using validated self-report scales. After study completion, participants in the control arm are granted access to the psychoeducation platform.
Who should consider this trial
Good fit: Women aged 18-65 who completed active breast cancer treatment at least 12 months ago, are in remission, can read and write Turkish, have internet access and a device for Zoom sessions, and can commit to the 6-week schedule are ideal candidates.
Not a fit: Patients with active recurrence or metastatic disease, current untreated psychiatric disorders, cognitive impairment, inability to use the internet, or who cannot commit to the online schedule are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, the program could reduce distress and fear of recurrence and improve quality of life for breast cancer survivors using a convenient online format.
How similar studies have performed: Previous web-based psychoeducation and psychosocial programs for cancer survivors have shown modest improvements in psychological outcomes, though results across studies are mixed.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female breast cancer survivors * Completed active breast cancer treatment (surgery, chemotherapy, radiotherapy) at least 12 months ago * Currently in remission (no evidence of active disease) * Age between 18-65 years * Able to read and write Turkish * Access to computer or smartphone with internet connection * Able to participate in online video sessions via Zoom * Willing to provide informed consent Exclusion Criteria: * Current cancer recurrence or metastatic disease * Active psychiatric disorder requiring treatment * Cognitive impairment that prevents participation in online sessions * Currently receiving active cancer treatment (excluding hormonal therapy) * Participation in another psychosocial intervention study * No internet access or inability to use web-based platforms * Male breast cancer patients * Unable to commit to 6-week program schedule
Where this trial is running
Istanbul
- Breast Cancer Outpatient Clinic — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Yasemin Nazlı, Clinical Nurse Specialist
- Email: yasemin.nazli@st.uskudar.edu.tr
- Phone: +905325025158
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.